A PERTH company is developing a treatment that may provide a breakthrough for sufferers of tinnitus.
Millions of people worldwide suffer from tinnitus, a ringing or buzzing sound in the ears resulting from auditory nerve disease.
Tinnitech was formed in 2001 to commercialise the patent pending technology developed by Curtin University researcher Dr Paul Davies.
According to the American Tinnitus Association, 50 million Americans suffer from the disease and there is no definitive treatment.
Tinnitech is currently conducting further research and commercialisation, with announcements to be made later this year, according to chief operating officer Michelle Norton.
“We are continuing the research of Dr Paul Davies at Curtin University aiming to commercialise a treatment for tinnitus,” Ms Norton said.
“We are extending the research and getting it to the stage of commercialisation and getting through the regulation process.”
Any further comment on the research team’s successes was not possible, she said, because testing results were not available.
“We are currently awaiting results of studies, which we should have in the middle of this year. Watch this space,” Ms Norton said.
The company successfully acquired a Biotechnology Innovation Fund grant of $250,000 last year.
